High expression of MiR-98 is a good prognostic factor in acute myeloid leukemia patients treated with chemotherapy alone
In conclusion, our results indicated that high miR-98 expression confers good prognosis in AML patients treated with chemotherapy alone. Patients with low miR-98 expression may benefit from allo-HSCT.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Ning Hu, Zhiheng Cheng, Yifan Pang, Hongmian Zhao, Li Chen, Chao Wang, Tong Qin, Qianyu Li, Yu Han, Jinlong Shi, Lin Fu Tags: Research Paper Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Genetics | Leukemia | Stem Cell Therapy | Stem Cells | Study | Transplants